Mar 17, 2015

Wrapping up ARIMMORA – Risk Assessment Workshop and Final General Assembly Meeting at IARC in Lyon, March 9 – 13, 2015

The EU-funded consortium on Advanced Research on Interaction Mechanisms of electroMagnetic exposures with Organisms for Risk Assessment (ARIMMORA) convened for the final time March 9 – 13, 2015 at the International Agency for Research on Cancer (IARC) in Lyon for a risk assessment workshop and final General Assembly meeting. The risk assessment document prepared during the workshop, which specifically addresses the weak association of childhood leukemia with exposure to extremely low-frequency magnetic fields (ELF-MF), is based a critical evaluation of studies conducted within the ARIMMORA project, set into the context of recent studies conducted outside the consortium as well as the opinion on general EMF-related health risk released March 6, 2015 by the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR).

The 22 scientific experts who met to write the ARIMMORA Risk Assessment included 18 consortium members, 2 advisory board members, and 2 external experts in childhood leukaemogenesis. The risk assessment will be published together with the final ARIMMORA report.

Front, from left: Benjamin Struchen (Swiss TPH), Dr. Gunde Ziegelberger (BfS), Dr. Meike Müller (ITEM)
Middle, from left:  Dr. David Schürmann (UNIBAS), Prof. Martin Röösli (Swiss TPH), Dr. Maren Fedrowitz (TIHO), Prof. Rony Seger (Weizmann), Prof. Niels Kuster (IT'IS), Friederike Erdmann (IARC), Dr. Joachim Schüz (IARC), Dr. Patricia Bounds (IT'IS), Melissa Manser (UNIBAS), Prof. Yngve Hamnerius (Chalmers)
Back, from left: Prof. Clemens Dasenbrock (ITEM), Dr. Myles Capstick (IT'IS), Prof. Primo Schär (UNIBAS), Dr. Christoph Schmid (Swiss TPH), Dr. Isidro Sanchez-Garcia (CSIC), Prof. Arndt Borkhardt (UKD), Prof. Kjeld Schmiegelow (RHC), Dr. César Cobaleda (CSIC), Dr. Paolo Ravazzani (CNR-IEIIT)